Steven C Jones has sold NEO and made no open-market buys since May 2016

Steven C. Jones is a corporate executive and independent director who serves on the board of NeoGenomics, Inc. as a Director and has been reported as Executive Vice President of Finance and Director of Investor Relations for the company.( At NeoGenomics, a cancer genetics diagnostics laboratory, he has focused on developing strategic initiatives, overseeing investor relations, and previously acting in senior finance roles that supported the company’s growth in oncology and hematology testing services.(

Beyond NeoGenomics, Jones holds multiple leadership positions in finance, telecommunications, and healthcare-related enterprises, including Chairman of T3 Communications, Inc., Chairman & Managing Partner of Aspen Capital Group LLC, President & Managing Director of Aspen Capital Advisors LLC, Chairman of Quantum Health Systems LLC, and Chairman & CEO of Gulf Pointe Capital, LLC.( His earlier career includes senior finance roles such as Chief Financial Officer at PEAK6 Group LLC, CTC Communications Group, Inc., and Fiera Group, Inc., as well as Vice President in the Investment Banking Group at Merrill Lynch & Co., Inc.( He serves or has served on multiple boards, including NeoGenomics Laboratories, Inc., ERP Maestro, Inc., XG Sciences, Inc., and SeqWright, Inc., and holds an undergraduate degree from the University of Michigan and an MBA from The Wharton School of the University of Pennsylvania.(

Written by Perplexity from public sources.